Myriad Genetics, Inc. (MYGN) vs Senseonics Holdings, Inc. (SENS)

A side-by-side comparison of Myriad Genetics, Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MYGN vs SENS

growth of $100 · dividends reinvested · last 10y
MYGN -77.8% (-14.0%/yr)SENS -86.3% (-18.0%/yr)MYGN compounded faster over this window
050100150200250Start $10020182020202220242026$22$14
MYGN SENS

MYGN vs SENS: by the numbers

  • •SENS is the larger company ($413M vs $411M market cap).
  • •Both run net losses; MYGN's is the smaller (-13.96% vs -225.34% net margin).
  • •SENS grew revenue faster over the past five years (35.10% vs 9.70% CAGR).

Metrics side by side

Valuation

MetricMYGNSENS
P/S ratio0.518.51
P/B ratio1.354.58

Profitability

MetricMYGNSENS
Gross margin68.83%44.71%
Operating margin-12.22%-193.83%
Net margin-13.96%-225.34%
ROE-37.05%-121.12%
ROIC-19.13%-71.22%

Growth (annualized)

MetricMYGNSENS
Revenue CAGR (5Y)9.70%35.10%
Total return CAGR (5Y)-32.02%-30.89%

Frequently asked

Which has grown faster, MYGN or SENS?
Over the past five years, SENS grew revenue faster — MYGN at a 9.70% CAGR versus SENS at 35.10%.
How have MYGN and SENS total returns compared?
Over the past 10 years, MYGN delivered -14.20% and SENS delivered -18.02% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.